AssetMark Inc’s Invesco Pharmaceuticals ETF PJP Stock Holding History

AssetMark Inc’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21	Closed	-$1.74K	–	2732
2024 Q4	$1.74K	Hold	21	–	–	﹤0.01%	2146
2024 Q3	$1.83K	Buy	+21	New	+$1.8K	﹤0.01%	1896
2015 Q4	–	Sell	-181	Closed	-$12K	–	1458
2015 Q3	$12K	Sell	181 -39	-18%	-$3.04K	﹤0.01%	468
2015 Q2	$17K	Hold	220	–	–	﹤0.01%	474
2015 Q1	$17K	Hold	220	–	–	﹤0.01%	423
2014 Q4	$15K	Sell	220 -50	-19%	-$3.33K	﹤0.01%	436
2014 Q3	$17K	Buy	270 +50	+23%	+$3.09K	﹤0.01%	422
2014 Q2	$13K	Hold	220	–	–	﹤0.01%	424
2014 Q1	$12K	Sell	220 -17,217	-99%	-$978K	﹤0.01%	388
2013 Q4	$933K	Sell	17,437 -30,599	-64%	-$1.53M	0.02%	265
2013 Q3	$2.21M	Buy	+48,036	New	+$2.19M	0.06%	163

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

AssetMark Inc's PJP Position: Q1 2025 in Review

AssetMark Inc sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2025, closing a stake of 21 shares — an estimated $1.74K sold.

AssetMark Inc first reported a position in PJP in Q3 2013 and held it in 11 quarters. The position peaked at $2.21M in Q3 2013. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2025.

AssetMark Inc reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
AssetMark Inc sold 21 Invesco Pharmaceuticals ETF shares in Q1 2025, an estimated $1.74K.
AssetMark Inc first reported a position in Invesco Pharmaceuticals ETF in Q3 2013 and held it in 11 quarters.
AssetMark Inc's Invesco Pharmaceuticals ETF position peaked at $2.21M in Q3 2013.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2025.

Based on AssetMark Inc's 13F filing for Q1 2025, filed 6 May 2025.